» Articles » PMID: 35223800

Organ-On-A-Chip: A Survey of Technical Results and Problems

Overview
Date 2022 Feb 28
PMID 35223800
Authors
Affiliations
Soon will be listed here.
Abstract

Organ-on-a-chip (OoC), also known as micro physiological systems or "tissue chips" have attracted substantial interest in recent years due to their numerous applications, especially in precision medicine, drug development and screening. Organ-on-a-chip devices can replicate key aspects of human physiology, providing insights into the studied organ function and disease pathophysiology. Moreover, these can accurately be used in drug discovery for personalized medicine. These devices present useful substitutes to traditional preclinical cell culture methods and can reduce the use of animal studies. In the last few years OoC design technology has seen dramatic advances, leading to a wide range of biomedical applications. These advances have also revealed not only new challenges but also new opportunities. There is a need for multidisciplinary knowledge from the biomedical and engineering fields to understand and realize OoCs. The present review provides a snapshot of this fast-evolving technology, discusses current applications and highlights advantages and disadvantages for biomedical approaches.

Citing Articles

Exploring oncology treatment strategies with tyrosine kinase inhibitors through advanced 3D models (Review).

Isinelli G, Failla S, Plebani R, Prete A Med Int (Lond). 2025; 5(2):13.

PMID: 39790707 PMC: 11707505. DOI: 10.3892/mi.2024.212.


Clinical Perspectives and Novel Preclinical Models of Malignant Pleural Mesothelioma: A Critical Review.

Ebrahimi A, Ak G, Ozel C, Izgordu H, Ghorbanpoor H, Hassan S ACS Pharmacol Transl Sci. 2024; 7(11):3299-3333.

PMID: 39539262 PMC: 11555512. DOI: 10.1021/acsptsci.4c00324.


Engineering human immune organoids for translational immunology.

Suhito I, Sunil C, Tay A Bioact Mater. 2024; 44:164-183.

PMID: 39474315 PMC: 11513670. DOI: 10.1016/j.bioactmat.2024.10.010.


Mapping the landscape of PSC-CM research through bibliometric analysis.

Li J, Han S, Yu F, Li T, Liao B, Liu F Front Cardiovasc Med. 2024; 11:1435874.

PMID: 39450232 PMC: 11499114. DOI: 10.3389/fcvm.2024.1435874.


Environmentally Controlled Microfluidic System Enabling Immune Cell Flow and Activation in an Endothelialised Skin-On-Chip.

Michielon E, Boninsegna M, Waaijman T, Fassini D, Spiekstra S, Cramer J Adv Healthc Mater. 2024; 13(29):e2400750.

PMID: 39370595 PMC: 11582514. DOI: 10.1002/adhm.202400750.


References
1.
Lu R, Radisic M . Organ-on-a-chip platforms for evaluation of environmental nanoparticle toxicity. Bioact Mater. 2021; 6(9):2801-2819. PMC: 7900603. DOI: 10.1016/j.bioactmat.2021.01.021. View

2.
Rothbauer M, Bachmann B, Eilenberger C, Kratz S, Spitz S, Holl G . A Decade of Organs-on-a-Chip Emulating Human Physiology at the Microscale: A Critical Status Report on Progress in Toxicology and Pharmacology. Micromachines (Basel). 2021; 12(5). PMC: 8143089. DOI: 10.3390/mi12050470. View

3.
Chen Y, Gao D, Wang Y, Lin S, Jiang Y . A novel 3D breast-cancer-on-chip platform for therapeutic evaluation of drug delivery systems. Anal Chim Acta. 2018; 1036:97-106. DOI: 10.1016/j.aca.2018.06.038. View

4.
Bein A, Shin W, Jalili-Firoozinezhad S, Park M, Sontheimer-Phelps A, Tovaglieri A . Microfluidic Organ-on-a-Chip Models of Human Intestine. Cell Mol Gastroenterol Hepatol. 2018; 5(4):659-668. PMC: 5924739. DOI: 10.1016/j.jcmgh.2017.12.010. View

5.
Wikswo J, Curtis E, Eagleton Z, Evans B, Kole A, Hofmeister L . Scaling and systems biology for integrating multiple organs-on-a-chip. Lab Chip. 2013; 13(18):3496-511. PMC: 3818688. DOI: 10.1039/c3lc50243k. View